Predictors of pleurodesis success

R. Mercer (Oxford, United Kingdom), N. Speck (Zurich, Switzerland), H. Jeffries (Oxford, United Kingdom), J. Macready (Oxford, United Kingdom), N. Kanellakis (Oxford, United Kingdom), N. Maskell (Bristol, United Kingdom), J. Pepperell (Taunton, United Kingdom), T. Saba (Blackpool, United Kingdom), A. West (London, United Kingdom), N. Ali (Mansfield, United Kingdom), R. Miller (London, United Kingdom), J. Corcoran (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), R. Hallifax (Oxford, United Kingdom), I. Psallidas (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom)

Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Session: Clinical management of pleural malignancies, including mesothelioma
Session type: Thematic Poster
Number: 2881
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Mercer (Oxford, United Kingdom), N. Speck (Zurich, Switzerland), H. Jeffries (Oxford, United Kingdom), J. Macready (Oxford, United Kingdom), N. Kanellakis (Oxford, United Kingdom), N. Maskell (Bristol, United Kingdom), J. Pepperell (Taunton, United Kingdom), T. Saba (Blackpool, United Kingdom), A. West (London, United Kingdom), N. Ali (Mansfield, United Kingdom), R. Miller (London, United Kingdom), J. Corcoran (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), R. Hallifax (Oxford, United Kingdom), I. Psallidas (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom). Predictors of pleurodesis success. 2881

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Success rate of talc pleurodesis
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019


Treatment success and survey in pleurodesis cases
Source: Eur Respir J 2006; 28: Suppl. 50, 39s
Year: 2006

Efficacy of thoracoscopic talc poudrage pleurodesis and predictive factors for its success in malignant pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 72s
Year: 2005

Long term outcome of primary spontaneous pneumothorax after talc pleurodesis
Source: Annual Congress 2004 - New diagnostic and therapeutic applications in bronchoscopy and thoracoscopy
Year: 2004


Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax
Source: Eur Respir J 2007; 30: 598-599
Year: 2007


Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax
Source: Eur Respir J 2007; 30: 598
Year: 2007


Videothoracoscopy is effective for the management of pneumothorax recurrences after talc pleurodesis
Source: Eur Respir J 2003; 22: Suppl. 45, 369s
Year: 2003

Talc pleurodesis by thoracoscopy in patients with primary spontaneous pneumothorax: a 10-year experience.
Source: International Congress 2019 – Interventional pulmonology: current pleural practice
Year: 2019

Morbidity and mortality after talc pleurodesis
Source: Eur Respir J 2003; 22: Suppl. 45, 509s
Year: 2003

Audit of success rate and complications of talc slurry pleurodesis for malignant pleural effusions
Source: Annual Congress 2008 - Pleural diseases and interventions
Year: 2008


Factors influencing the rate of the first recurrence after drainage in spontaneous pneumothorax
Source: Annual Congress 2009 - Pleural problems, congenital lesions and novel technical devices
Year: 2009

Outcomes of daycase medical thoracoscopy and pleurodesis
Source: International Congress 2019 – New insights into pleural and bronchoscopic interventions
Year: 2019


Predictors of successful pleurodesis for patients with malignant pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 493s
Year: 2004

Impact of pneumothorax as complication of endobronchial valve treatment on patient-reported outcomes
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021


Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax
Source: Eur Respir J 2007; 29: 757-760
Year: 2007



Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study
Source: Eur Respir J 2011; 38: 770-773
Year: 2011



Predictors of weaning success in patients requiring prolonged invasive mechanical ventilation
Source: Virtual Congress 2021 – Mechanical ventilation and weaning
Year: 2021


Safety and efficacy of pleurodesis with thoracoscopic doxycycline poudrage in malignant pleural effusion
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011


Efficacy and safety of autologous blood pleurodesis versus talc pleurodesis in patients with malignant pleural effusions: Preliminary results
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012

How much prevention of postoperative recurrence by staple-line reinforcement on thoracoscopic blebectomy for spontaneous pneumothorax?
Source: International Congress 2018 – Thoracic surgery, pleural effusions and other general thoracic surgery
Year: 2018